756 related articles for article (PubMed ID: 9728943)
1. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
2. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
[TBL] [Abstract][Full Text] [Related]
3. Patterns of brain activation in people at risk for Alzheimer's disease.
Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
5. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
6. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
Lehtovirta M; Soininen H; Laakso MP; Partanen K; Helisalmi S; Mannermaa A; Ryynänen M; Kuikka J; Hartikainen P; Riekkinen PJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):644-9. PubMed ID: 8648331
[TBL] [Abstract][Full Text] [Related]
7. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
9. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.
Geroldi C; Pihlajamäki M; Laakso MP; DeCarli C; Beltramello A; Bianchetti A; Soininen H; Trabucchi M; Frisoni GB
Neurology; 1999 Nov; 53(8):1825-32. PubMed ID: 10563634
[TBL] [Abstract][Full Text] [Related]
10. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
[TBL] [Abstract][Full Text] [Related]
11. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
Jelic V; Julin P; Shigeta M; Nordberg A; Lannfelt L; Winblad B; Wahlund LO
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):59-65. PubMed ID: 9221969
[TBL] [Abstract][Full Text] [Related]
14. Family history of Alzheimer's disease and hippocampal structure in healthy people.
Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
Am J Psychiatry; 2010 Nov; 167(11):1399-406. PubMed ID: 20686185
[TBL] [Abstract][Full Text] [Related]
15. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
16. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu T; Helm JL; Wierenga CE
Brain Imaging Behav; 2020 Apr; 14(2):369-382. PubMed ID: 32048144
[TBL] [Abstract][Full Text] [Related]
17. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
[TBL] [Abstract][Full Text] [Related]
19. APOE modifies the interaction of entorhinal cerebral blood flow and cortical thickness on memory function in cognitively normal older adults.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu TT; Helm JL; Wierenga CE
Neuroimage; 2019 Nov; 202():116162. PubMed ID: 31493534
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
